» Articles » PMID: 24351745

Prevalence of COPD and Tobacco Smoking in Tunisia--results from the BOLD Study

Overview
Publisher MDPI
Date 2013 Dec 20
PMID 24351745
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

In Tunisia, there is a paucity of population-based data on Chronic Obstructive Pulmonary Disease (COPD) prevalence. To address this problem, we estimated the prevalence of COPD following the Burden of Lung Disease Initiative. We surveyed 807 adults aged 40+ years and have collected information on respiratory history and symptoms, risk factors for COPD and quality of life. Post-bronchodilator spirometry was performed and COPD and its stages were defined according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines. Six hundred and sixty one (661) subjects were included in the final analysis. The prevalence of GOLD Stage I and II or higher COPD were 7.8% and 4.2%, respectively (Lower Limit of Normal modified stage I and II or higher COPD prevalence were 5.3% and 3.8%, respectively). COPD was more common in subjects aged 70+ years and in those with a BMI < 20 kg/m2. Prevalence of stage I+ COPD was 2.3% in <10 pack years smoked and 16.1% in 20+ pack years smoked. Only 3.5% of participants reported doctor-diagnosed COPD. In this Tunisian population, the prevalence of COPD is higher than reported before and higher than self-reported doctor-diagnosed COPD. In subjects with COPD, age is a much more powerful predictor of lung function than smoking.

Citing Articles

Prevalence and Associated Factors of Chronic Obstructive Pulmonary Disease Among Adults in Neno District, Malawi: A Cross-Sectional Analytical Study.

Zaniku H, Connolly E, Aron M, Matanje B, Ndambo M, Complex Talama G Int J Chron Obstruct Pulmon Dis. 2024; 19:389-401.

PMID: 38343494 PMC: 10854231. DOI: 10.2147/COPD.S444378.


Associations between different body mass index and lung function impairment in Chinese people aged over 40 years: a multicenter cross-sectional study.

Tang Y, Zhang L, Zhu S, Shen M, Cheng M, Peng F BMC Pulm Med. 2024; 24(1):30.

PMID: 38212744 PMC: 10785338. DOI: 10.1186/s12890-024-02844-x.


Reduced forced vital capacity is independently associated with, aging, height and a poor socioeconomic status: a report from the Tunisian population-based BOLD study.

Hsan S, Lakhdar N, Harrabi I, Zaouali M, Burney P, Denguezli M BMC Pulm Med. 2022; 22(1):267.

PMID: 35818049 PMC: 9275164. DOI: 10.1186/s12890-022-02062-3.


Anthropometric, Psychosocial, Physiological, and Postural Observances During Ramadan in Men With Chronic Obstructive Pulmonary Disease.

Mekki M, Paillard T, Bouhlel E, Shephard R, Tabka Z, Trabelsi Y Am J Mens Health. 2022; 16(1):15579883221078141.

PMID: 35184575 PMC: 8864263. DOI: 10.1177/15579883221078141.


Effects of specific inspiratory muscle training combined with whole-body endurance training program on balance in COPD patients: Randomized controlled trial.

Tounsi B, Acheche A, Lelard T, Tabka Z, Trabelsi Y, Ahmaidi S PLoS One. 2021; 16(9):e0257595.

PMID: 34555068 PMC: 8460029. DOI: 10.1371/journal.pone.0257595.


References
1.
Mannino D, Gagnon R, Petty T, Lydick E . Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000; 160(11):1683-9. DOI: 10.1001/archinte.160.11.1683. View

2.
Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S . Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007; 176(8):753-60. DOI: 10.1164/rccm.200612-1749OC. View

3.
Pembroke T, Rasul F, Hart C, Davey Smith G, Stansfeld S . Psychological distress and chronic obstructive pulmonary disease in the Renfrew and Paisley (MIDSPAN) study. J Epidemiol Community Health. 2006; 60(9):789-92. PMC: 2566028. DOI: 10.1136/jech.2005.042150. View

4.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. PMC: 10790329. DOI: 10.1016/S0140-6736(12)61728-0. View

5.
Pellegrino R, Viegi G, Brusasco V, Crapo R, Burgos F, Casaburi R . Interpretative strategies for lung function tests. Eur Respir J. 2005; 26(5):948-68. DOI: 10.1183/09031936.05.00035205. View